Skip to content

Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes

Jom Mama Project - Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02617693
Acronym
Jom Mama
Enrollment
552
Registered
2015-12-01
Start date
2015-11-23
Completion date
2017-12-09
Last updated
2019-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia. The aim of this study is to assess the efficacy of a pre-pregnancy life style intervention to reduce the risk of diabetes and prediabetes.

Interventions

BEHAVIORALlifestyle intervention

Evaluation of lifestyle intervention combining behavioural change councelling and utilisation of E-health platform. The intervention consists of a combination of behaviour change counselling and support through six contact-points with CHPs (community health promoter) and access to a personalised mobile application.

Standard of care for pre-pregnancy health. Subjects will be reminded of their endpoint measurement visit towards the end of the intervention period through a phone call.

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial * Nulliparity * Not pregnant at the time of signing informed consent * Own a smartphone with either Android system version 4.1 and above or iOS system 7.0 and above with internet access

Exclusion criteria

* Female subject undergoing treatment for type 1 or 2 diabetes mellitus * Subjects not residing in the district of Seremban

Design outcomes

Primary

MeasureTime frame
Difference in waist circumferenceMonths 0-8

Secondary

MeasureTime frame
Change in waist-to-height ratio (WHtR)Month 0, Month 8
Change in waist-to-hip ratioMonth 0, Month 8
Change in weightMonth 0, Month 8
Change in HbA1c (Glycosylated haemoglobin))Month 0, Month 8
Change in the fasting lipid profile (total cholesterol [TC], low density lipoprotein cholesterol[LDL-C], high density lipoprotein cholesterol[HDL-C], triglycerides [TG])Month 0, Month 8
Change in BMI (Body Mass Index)Month 0, Month 8
Change in the level of health literacy, as measured by the European Health Literacy Survey Questionnaire (HLC-EU-Q)Month 0, Month 8
Change in dietary intake, as measured by the Frequency Food Questionnaire (FFQ) that is used in National Health Surveys in MalaysiaMonth 0, Month 8
Change in dietary intake, as measured by a Frequency Food Questionnaire (FFQ)Month 0, Month 8
Change in physical activity and sedentary behaviour, as measured by the International Physical Activity Questionnaire (IPAQ) used in National Health Surveys in MalaysiaMonth 0, Month 8
Change in stress levels, as measured by the Depression Anxiety and Stress Scale 21-items (DASS-21) used in National Health Surveys in MalaysiaMonth 0, Month 8
Change in blood pressure (SBP (systolic blood pressure) and DBP(diastolic blood pressure))Month 0, Month 8

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026